MTST Stock UPDATES Metastat Inc (MTST) 0.9000 08/03/2014 15:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Metastat Inc (MTST) 0.9000 $MTST

MetaStat, Inc. Announces Memorandum of Understanding to Transfer its Therapeutic Business
ACCESSWIRE - Thu Jul 17, 8:25AM CDT
MONTCLAIR, NJ. / ACCESSWIRE / MetaStat, Inc. (OTCQB: MTST), a life science company focused on understanding and treating systemic metastasis, announced today that on July 14, 2014 it entered into a binding Memorandum of Understanding (MOU) to transfer its therapeutic assets to a newly formed private company, ASET Therapeutics. ASET will be led by David Epstein, former chief scientific officer of OSI Pharmaceuticals, who will remain as a director of MetaStat for at least 6 months following consummation of the transaction.

ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc.
PR Newswire - Mon Jul 14, 7:00AM CDT
Today, ATS Labs, Inc. (ATS), majority owned by Ampersand Capital Partners, announced that it acquired the assets of MicroTest Labs, Inc. (MTL) of Agawam, MA. The acquisition of MTL is the first step in the strategy of ATS to expand its microbiology and chemistry laboratory services platform to support the medical device and biopharmaceutical industries. The combined companies will soon be known as Accuratus Lab Services, a name that personifies the quality and accuracy of testing results and scientific solutions that support the antimicrobial, consumer product, medical device, and biopharmaceutical industries.

MetaStat, Inc. Closes Equity Financing
ACCESSWIRE - Wed Jul 02, 11:18AM CDT
MONTCLAIR, NJ / ACCESSWIRE / July 2, 2014 / MetaStat, Inc. (OTCQB: MTST), a life science company focused on understanding and treating systemic metastasis, announced today that on June 30, 2014, it entered into a securities purchase agreement in a private placement totaling $5.7 million, inclusive of the automatic exchange of outstanding convertible promissory notes in the aggregate principal amount of approximately $3.3 million.

Photo Release -- Fish Embryo Toxicology Testing is Better Alternative for Whole-Effluent Testing, Advises New Whitepaper from Microtest Laboratories
GlobeNewswire - Mon Jun 16, 9:38AM CDT
As pharmaceutical, chemical and other manufacturers come under increased scrutiny for their Whole Effluent Toxicity (WET), a new methodology to measure WET -- fish embryo toxicity (FET) testing -- promises to better determine the potential environmental impact of their products and waste water on the environment.

MetaStat, Inc. Announces Publication of Results of its MetaSite Breast Test in the Journal of the National Cancer Institute (JNCI)
ACCESSWIRE - Wed Jun 04, 5:04AM CDT
MONTCLAIR, N.J. / ACCESSWIRE / June 04, 2014 / MetaStat, Inc. (OTCQB: MTST), a life science company focused on commercializing novel technologies that uniquely understand systemic metastasis, which is responsible for 90% of fatalities in most solid tumor cancers, announced today that positive results from a study of its MetaSite Breast test were published online in the Journal of the National Cancer Institute (JNCI). The study paper is titled "Tumor Microenvironment of Metastasis and Risk of Distant Metastasis of Breast Cancer." The MetaSite Breast test, a diagnostic assay that quantifies the number of "tumor microenvironments of metastasis" ("TMEM" or "MetaSite" in tumor specimens, showed a strong and statistically significant association with the risk of distant spread, or metastasis, for the most common type of breast cancer.

Disinfectant Qualification Questions Are Answered for Sterile Drug Manufacturers in New White Paper From Microtest Laboratories
GlobeNewswire - Mon Jun 02, 8:33AM CDT
Manufacturers of sterile drug products are required by the FDA to undertake disinfectant qualification studies to determine the effectiveness of their disinfecting agents. A new white paper, "Disinfectant Qualifications: Insight and Perspective," answers the most frequently asked questions about conducting a successful study. Download the paper from Microtest Laboratories at http://www.microtestlabs.com/disinfectant-qualifications.

MetaStat, Inc. Announces Issuance of New U.S. Patent for its MetaSite Breast(tm) Test
ACCESSWIRE - Thu Mar 06, 7:41AM CST
MONTCLAIR, N.J. / ACCESSWIRE / March 6, 2014 / MetaStat, Inc. (OTCQB : MTST), a life science company focused on understanding and treating systemic metastasis, announced today that the United States Patent and Trademark Office (USPTO) issued on February 4, 2014, U.S. Patent No. 8,642,277 entitled: "TUMOR MICROENVIRONMENT OF METASTASIS (TMEM) AND USES THEREOF IN DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMORS." The named inventors of this new patent are John Condeelis, Thomas E. Rohan, Frank B. Gertler, and Joan G Jones.

MetaStat, Inc. to Present at the 26th Annual ROTH Conference
Marketwire - Wed Feb 26, 6:15AM CST
MetaStat, Inc. (OTCQB: MTST), a life science company focused on understanding and treating systemic metastasis, announced today that it has been invited to present at the upcoming 26th Annual ROTH Conference. The conference will be held on March 9-12, 2014 at The Ritz-Carlton Laguna Niguel in Dana Point, California. MetaStat will be presenting on Wednesday, March 12, 2014 at 12:30 pm (PT).

Rightscorp Innovative Business Model Persuades File Sharing Users to Pay Intellectual Property Holders: Updates on Recent Coverage
PR Newswire - Tue Feb 25, 6:00AM CST
A California company, Rightscorp, Inc. (OTCQB: RIHT) is receiving the blessing of major music and movie studios by going after illegal distributors on file-sharing sites in a different way than previous enforcement methods. Shareholders seem encouraged as well, especially since this type of low-level piracy is likely to continue.

Biotech Breakthroughs Brings Powerful Cancer Testing and Drugs to Market
PR Newswire - Tue Feb 18, 6:00AM CST
New trial confirms MetaSite Breast test's ability to predict breast cancer metastasis. MetaSite Breast would allow doctors and patients to customize breast cancer treatment based on the cancer's probability of metastasizing.

Metastat Analyst Report Provides Investor Opportunity
PR Newswire - Mon Feb 17, 6:00AM CST
With the tremendous run in the biotech sector over the last 12 months many have overlooked this micro-cap gem that has terrific upside potential. Metastat, Inc. (OTCQB: MTST) is a life sciences company that provides proprietary platform technologies for the treatment of systemic metastasis. This micro-cap stock is topping the list for many analyst in the coming year.

MetaStat, Inc. Launches Scientific Advisory Board for Therapeutics
ACCESSWIRE - Mon Feb 10, 7:00AM CST
MONTCLAIR, NJ / ACCESSWIRE / February 10, 2014 / MetaStat, Inc. (OTCQB: MTST), a life science company focused on understanding and treating systemic metastasis, today announced the appointments of scientific and clinical leaders from the fields of RNA biology, alternative splicing, and therapeutic resistance in cancer to its newly formed scientific advisory board for therapeutics. The members include David M. Epstein, Ph.D, Eric Winer, M.D., Adrian Krainer, Ph.D., Mariano-Garcia Blanco, M.D., Ph.D., Michael Hemann, M.D., Ph.D. and Frank Gertler, Ph.D.

MetaStat, Inc. to Present at the 2014 BIO CEO & Investor Conference in New York City on February 11, 2014
ACCESSWIRE - Wed Feb 05, 8:03AM CST
MONTCLAIR, NJ / February 5, 2014 / ACCESSWIRE / MetaStat, Inc. (OTCQB: MTST), a life science company focused on understanding and treating systemic metastasis, today announced that the company's Chief Executive Officer, Oscar Bronsther, M.D., will present at the BIO CEO & Investor Conference on Tuesday, February 11, 2014 at 1:30 p.m. EST. The conference will be held at the Waldorf Astoria in New York. Dr. Bronsther will discuss MetaStat's novel diagnostic and therapeutic approaches to systemic metastasis, the process by which cancer spreads from a primary tumor through the bloodstream to other areas of the body.

Fundamentals of Endotoxin Testing for Medical Device Manufacturers are Detailed in New Technical Brief
Business Wire - Tue Jan 14, 9:12AM CST
The fundamentals of endotoxin testing for medical device manufacturers -- from definition to assay acceptance criteria --are detailed in new technical brief available from Microtest Laboratories.

MetaStat, Inc. to Present at Biotech Showcase(TM) 2014 in San Francisco
Marketwire - Wed Jan 08, 11:12AM CST
MetaStat, Inc. (OTCQB: MTST), a life science company focused on understanding and treating systemic metastasis, today announced that the company's Chief Executive Officer, Oscar Bronsther, M.D., will present at the Biotech Showcase(TM) 2014 on Wednesday, January 15th at 9:30am PST. Dr. Bronsther will discuss MetaStat's novel diagnostic and therapeutic approaches to systemic metastasis, the process by which cancer spreads from a primary tumor through the bloodstream to other areas of the body. To arrange a one-on-one meeting with management, please contact Andrew Haag at mtst@irthcommunications.com or 1-866-976-IRTH.

Fidelity & Guaranty Life Holdings, Inc. Announces Year End 2013 Conference Call for Bondholders
PR Newswire - Tue Jan 07, 8:52AM CST
Fidelity & Guaranty Life Holdings, Inc. ("FGLH" today announced the date and time of its quarterly bondholder conference call for the Fiscal year ended September 30, 2013. The call is open to all holders of Fidelity & Guaranty Life Holdings, Inc. 6.375% senior unsecured notes due 2021.

MetaStat, Inc. Announces Issuance of U.S. Patent for Its MenaCalc(TM) Platform
Marketwire - Mon Dec 23, 7:30AM CST
MetaStat, Inc. (OTCQB: MTST), a life science company focused on understanding and treating systemic metastasis, announced today that the United States Patent and Trademark Office (USPTO) has issued US Patent Number US 8,603,738 entitled: "METASTASIS SPECIFIC SPLICE VARIANTS OF MENA AND USES THEROF IN DIAGNOSIS, PROGNOSIS, AND TREATMENT OF TUMORS", Inventors: John Condeelis, Sumanta Goswami, Frank Gertler, and Paola Nistico.

MetaStat Announces Poster Presentation at the 2013 San Antonio Breast Cancer Symposium
Marketwire - Tue Dec 17, 9:13AM CST
MetaStat, Inc. (OTCBB: MTST), a life sciences company focused on understanding and treating systemic metastasis, today announced data on the company's licensed metastatic breast cancer diagnostic has been presented in Poster Session P2-11-03 entitled "A tumor microenvironment of metastasis (TMEM) biomarker in early breast cancer provides prognostic information that is complementary to IHC4: A prospective validation study" at the CTRC-AACR 2013 San Antonio Breast Cancer Symposium on December 10-14, 2013, in San Antonio, Texas.



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Insider Risk Makes Human Judgment a Security Priority

Updated Category News Views 127

A badge, a password, and a locked gate can all look reassuring right up until the person holding them starts to crack. Signpost Six's new report, The Psychology of Insider Risk, lands on an uncomfortable truth: the most consequential security weakness may not be a system at all. It may be an employee under strain, in conflict, in debt, making a mistake, or being quietly...

Continue Reading
U.S. Patriot's Veteran Hiring Earns a Real National Nod

Updated Category News Views 5

A workforce award can be cheap wallpaper, but this one has some heft. U.S. Patriot, the veteran-founded and veteran-led military goods retailer owned by GALLS, landed on Military Times’ 2026 Best for Vets: Employers list, placing third in retail and first in Kentucky. The recognition covers 250 organizations, and this is U.S. Patriot’s fourth consecutive appearance....

Continue Reading
VeriSilicon's New AI/AR Glasses Tech: Game-Changer?

Updated Category News Views 271

VeriSilicon Unveils Next-Generation Subsystem There's some sizzle in the air with VeriSilicon's latest move in the wearable tech arena. They’ve launched a low-power, high-performance subsystem aimed squarely at AI and augmented reality glasses. Now, these gizmos aren't just the stuff of science fiction. Thanks to their Nano-XR series, reality might just get a splash...

Continue Reading
Ambition Links Call Scoring to the Coaching Room Faster

Updated Category News Views 13

A sales call dies twice when nobody turns the recording into practice. First it ends with the prospect, then it vanishes into a pile of transcripts, dashboards, and manager good intentions. Ambition’s new Call Intelligence feature is aimed squarely at that second failure. It brings Gong calls, transcripts, scorecards, and trackers into Ambition’s coaching workflow,...

Continue Reading
Trilith Holiday Tour Blends Film Access and Giving

Updated Category News Views 71

Snow machines, trolley rides, and a mental-health subsidy are sharing the same stage in Fayetteville this holiday season. That is an unusual mix, but it fits Trilith Foundation’s stated mission better than another generic lights-and-cocoa event ever could. From Nov. 21 through Dec. 31, the Foundation is turning its guided Trilith Studios tour into a seasonal experience...

Continue Reading
illumine Targets Childcare Chain Control and Risk Gaps

Updated Category News Views 30

Expansion Gets Messy Before It Gets Impressive Childcare operators do not usually stumble because they forgot how to care for children; they stumble because the back office fractures as the network grows. One center handles fees one way, another lets enrollment leads work a different funnel, and headquarters discovers too late that its reports are arguing with each other....

Continue Reading
Scribd’s First Safety Report Shows Enforcement at Scale

Updated Category News Views 292

Forty-seven million enforcement actions is not a decorative statistic Scribd finally put some hard numbers on a problem most document platforms prefer to discuss in foggy corporate language. Its first transparency report, covering January through June 2026, says the company took more than 47 million moderation actions across Scribd and Slideshare. That is a hulking...

Continue Reading
Skanska Adds $80M U.S. Tech Facility Contract to Orders

Updated Category News Views 107

An $80 million add-on is the sort of construction news that looks modest until you remember what it says about the customer relationship. Skanska has won an additional contract from an existing client for a U.S. tech facility, worth roughly SEK 760 million, and it will enter U.S. order bookings in the fourth quarter of 2026. No fireworks, no grand strategic...

Continue Reading
Inhibrx Ewing Data Gives Ozekibart a Real Clinical Signal

Updated Category News Views 165

Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...

Continue Reading
Vuzix Bets on Lightweight Color Glasses for OEM Partners

Updated Category News Views 107

Forty grams is where this story gets interesting, because faces are ruthless product testers. People will tolerate plenty of clever technology right up until it pinches, looks goofy, leaks light, or makes them feel like they are wearing a science project. Vuzix is trying to clear that hurdle with Ultralite Color, a full-color AI eyewear reference platform built for OEM...

Continue Reading

Top 5 Most Recently Viewed Articles

Bioretec's Innovative Annual Report Showcases New Progress

Updated Category News Views 188

Bioretec Ltd's Annual Report Overview Bioretec Ltd has recently published its annual report for 2024, offering insights into the company's growth and achievements over the past year. This report showcases the advancements made in biodegradable orthopedic implants, positioning the company at the forefront of innovative healthcare solutions. Company Highlights Bioretec...

Continue Reading
Market Overview: Asia Stocks See Fluctuations Amid Election Fears

Updated Category News Views 251

Market Dynamics in Asia: A Closer Look In recent trading sessions, Asian stocks demonstrated muted movements in response to an absence of compelling trading signals, while Japanese shares experienced a notable decline driven by impending democratic choices. Investors are particularly focused on the Japanese electoral scene, which is expected to significantly influence...

Continue Reading
TScan Therapeutics Secures $52.5 Million Loan to Support Growth

Updated Category News Views 113

TScan Therapeutics Secures $52.5 Million Loan from Silicon Valley Bank WALTHAM, Mass. — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company dedicated to developing innovative therapies for cancer treatment, has announced an exciting milestone. The company has entered into a term loan facility with Silicon Valley Bank (SVB) that offers up to...

Continue Reading
Celebrating Four Years of SpaceX's Starlink Internet Service

Updated Category News Views 385

Four Years of Starlink Connectivity Four years ago, SpaceX, under the visionary leadership of Elon Musk, began its journey in satellite internet services by activating Starlink for its first paying customer. This significant milestone was established on a date that marks the beginning of a transformative era for internet connectivity. Impact of Starlink on Global Internet...

Continue Reading
AllenComm Receives Esteemed Recognition in eLearning Field

Updated Category News Views 167

AllenComm Earns Top Honor for eLearning Localization AllenComm, a prominent player in the realm of innovative learning experiences, has recently been recognized as one of the Top Content Providers for eLearning Localization by a well-regarded industry source. This accolade reflects the company's dedication to delivering high-quality, effective educational solutions that...

Continue Reading